Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.19M Buy
+259,007
New +$3.06M ﹤0.01% 1658
2025
Q2
Sell
-445,580
Closed -$610K 2650
2025
Q1
$610K Buy
445,580
+811
+0.2% +$1.39K ﹤0.01% 2454
2024
Q4
$1.12M Buy
444,769
+80,684
+22% +$221K ﹤0.01% 2320
2024
Q3
$994K Buy
+364,085
New +$1.03M ﹤0.01% 2400
2024
Q1
Sell
-71,342
Closed -$152K 2533
2023
Q4
$152K Hold
71,342
﹤0.01% 2508
2023
Q3
$141K Hold
71,342
﹤0.01% 2545
2023
Q2
$215K Hold
71,342
﹤0.01% 2556
2023
Q1
$215K Buy
71,342
+46,938
+192% +$171K ﹤0.01% 2556
2022
Q4
$105K Buy
24,404
+5,304
+28% +$36K ﹤0.01% 2492
2022
Q3
$149K Hold
19,100
﹤0.01% 2647
2022
Q2
$106K Buy
+19,100
New +$125K ﹤0.01% 2644

Other funds holding ERAS

UBS AM's ERAS Position: Q1 2026 in Review

UBS AM opened a new position in Erasca (ERAS) in Q1 2026: 259,007 shares worth $4.19M. The stake represents ﹤0.01% of the portfolio and ranks #1658 among its holdings. This is a return to the name: UBS AM previously reported a position in ERAS as recently as Q1 2025.

UBS AM first reported a position in ERAS in Q2 2022 and has held it in 11 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • UBS AM held 259,007 shares of Erasca worth $4.19M as of Q1 2026.
  • Erasca was a new UBS AM position in Q1 2026.
  • Erasca made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1658 holding.
  • UBS AM first reported a position in Erasca in Q2 2022 and has held it in 11 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.